Focal Therapy Finding Its Niche for Intermediate-Risk Prostate Cancer Prostate cancer focal therapies include cryotherapy, irreversible electroporation ablation (IRE), & high-intensity focused ultrasound (HIFU).

Focal therapy is emerging as a standard management strategy for select men with intermediate-risk prostate cancer.

However, it is not for all men, according to experts who debated the topic at #AUA25. Read our latest feature: www.renalandurologynews.com/features/foc...

Grade Group 1, ASAP Found on Prostate Biopsy Warrant Concern - Renal and Urology News “Benign” findings on prostate biopsy in some men may be more serious than previously thought.

Grade group 1 and ASAP on prostate biopsy predict future prostate cancer risk and should not be ignored.
www.renalandurologynews.com/reports/grad... #AUA25

Novel Therapies for Advanced Urothelial Carcinoma Compared Using AI Tool - Renal and Urology News Investigators used the Shiny method, which employs artificial intelligence, to indirectly compare the efficacy of novel systemic therapies for urothelial cancer using phase 3 trial data.

Using the Shiny method, a more nuanced approach to meta-analysis, investigators determined that enfortumab vedotin plus pembrolizumab outperforms chemotherapy-based regimens for urothelial carcinoma.
www.renalandurologynews.com/reports/urot... #AUA25

Truly honored to serve as an abstract reviewer for #AUA25 alongside giants in Urology and mentors who’ve shaped my journey!

Grateful to be one of the youngest ever to do so!

#AUA25

Mitchell Huang, MD, on the link between obesity and pain on transperineal biopsy Recent data suggest that obesity may be a risk factor for increased pain on transperineal biopsy.

Resident physician, Mitchell Huang, MD, discusses the link between obesity and pain on transperineal biopsy. #Prostate #AUA25 @urologytimes.bsky.social @nufeinbergmed.bsky.social
www.urologytimes.com/view/mitchel...

Get closer to the conversations that matter in #NMIBC management with insights from #AUA25. Visit Medthority now to watch Mark D Tyson II discuss the latest trial data and novel treatment options #MedSky #MedicalEducation #Oncology #BladderCancerAwarenessMonth

ow.ly/ocOi50VPkwe

Ultra-Low PSA Response With Darolutamide/ADT Correlates With Better Outcomes in mHSPC Ultra-low PSA responses were linked with prolonged rPFS and delayed times to mCRPC and PSA progression for patients with mHSPC treated with darolutamide.

Ultra-Low PSA Response With Darolutamide/ADT Correlates With Better Outcomes in mHSPC
#AUA25 #ProstateCancer
www.onclive.com/view/ultra-l...

Are patients undergoing intralesional collagenase Clostridium histolyticum injection therapy for Peyronie’s disease compliant? 7-year analysis from a tertiary care men’s health center academic.oup.com/jsm/article/...

Great seeing UCI ex-fellow Dr. Lumbiganon🇹🇭 presenting at Global Gateway #AUA25!

Find out what's next for non-muscle-invasive bladder cancer (#NMIBC) prognosis and treatment with congress highlights from #AUA25, including the latest trial data on advanced delivery systems for intravesical chemotherapy #MedSky #MedicalEducation #BladderCancer

ow.ly/rgcH50VLYEw

Newsworthy scientific abstract from #aua25

In >1 M post menopausal women, they found Vaginal estrogen~

🔘 22% ⬇️ hospitalizations
🔘 51% ⬇️ sepsis
🔘 73% ⬇️ mortality

Coincides w aua sufu AUGS #gsm guideline release!

#wearesufu

Oncology Experts Highlight the Key Data and Top Abstracts From AUA 2025 Experts revisit the most intriguing abstracts and data they saw presented at the 2025 American Urological Association Annual Meeting.

Oncology Experts Highlight the Key Data and Top Abstracts From AUA 2025 @alirezaghoreifi.bsky.social #AUA25 #blcsm www.onclive.com/view/oncolog...

Subgroup Analysis Shows No Key Differences Between High-Grade Recurrence, Cancer Progression Outcomes in BCG-Unresponsive NMIBC Among 3 subgroups of patients with BCG-unresponsive NMIBC, no significant clinical differences were identified regarding rates of high-grade recurrence.

Subgroup Analysis Shows No Key Differences Between High-Grade Recurrence, Cancer Progression Outcomes in BCG-Unresponsive #NMIBC #AUA25 #oncology

www.onclive.com/view/subgrou...

At #AUA25, we partnered with the American Urological Association on an AUA TV video segment highlighting how our non-viral gene therapy platform is pushing the boundaries in developing bladder cancer treatments.

Watch the full video here: www.auanet.org/AUA2025/atte...

We had an amazing time at #AUA25!

The team enjoyed many insightful sessions, culminating with a wonderful alumni reception. We are so proud of our faculty & trainees for their powerful abstracts & presentations, and our trainees for their well-deserved awards!

Padeliporfin VTP Therapy Yields Complete Responses With Manageable Safety in Low-Grade, Upper Tract Urothelial Cancer Padeliporfin vascular targeted photodynamic therapy was safe and generated responses in low-grade, upper tract urothelial cancer.

Padeliporfin VTP Therapy Yields Complete Responses With Manageable Safety in Low-Grade, Upper Tract Urothelial Cancer #AUA25 #blcsm #oncology www.onclive.com/view/padelip...

Brilliant session focused entirely on spatial multiomics @theaacr.bsky.social #AUA25

Well said @tanevski.bsky.social "Cancer is a spatial disease-spatialomics is the future of cancer science"!

Wonderful composite spatial data from Linghua Wang @mdanderson.bsky.social
www.nature.com/articles/s41...

Just presented my podium talk at #AUA25 this morning!
I shared our study on association of systemic inflammatory markers and semen quality.
Huge thanks to my mentor Dr Eisenberg and our amazing team at Stanford Urology for all the support!

That’s a wrap on #AUA25 for Team IP!

See you in Washington DC for #AUA26! 🇺🇸

The @osuwexmed.bsky.social Comprehensive Kidney Stone Program is a nationally recognized, multidisciplinary leader in the treatment & prevention of kidney stones. See why OSU is at the forefront of kidney stone research now. #AUA25 youtu.be/BBBuzJgqsE4

The @clevelandclinic.bsky.social Center for Endourology & Stone Diseases is transforming kidney stone treatment with cutting-edge technology & research. Discover how they're minimizing risks & enhancing recovery for all patients. #AUA25 youtu.be/kFZDR2xa1Fo

Wrapping up an incredible #AUA25 in Las Vegas today. The exchange of ideas and advancements in #urology have been truly inspiring. Thank you to all who made it memorable. Until next time! #menshealthexpert #penileprosthesis

The Male Fertility & Peyronie’s Clinic is a world leader in male infertility & Peyronie’s disease. Through pioneering research & innovation, see how they continue to set new standards in men's health. #AUA25 youtu.be/dJnVgbDS5mc

Discover the benefits of integrated care with Urology of Indiana! By integrating a comprehensive system of urological care & addressing a wide array of conditions under 1 roof, they're improving patient care & outcomes for all. #AUA25 youtu.be/CC6tKRM2O64

We’re looking forward to Dr. Al Hussein’s final abstract at #AUA25 this morning!

We hope to see you there.

Patient Perspectives are essential to any field in medicine & the AUA made sure to include them as a part of #AUA25. Watch now as we catch up with several of the patients who brought their insights to the meeting. youtu.be/2ve4FRh6_Ho

It's the moment #AUA25 has been waiting for - who are the most knowledgable resident in urology? AUA TV joins the final of the Residents Bowl to find out who won & hear from some of the winners what it takes to be the very best! youtu.be/Gn709RpYqz4

Watch now as 2025 AUA President Dr. Stephen Nakada walks us through his highlights from #AUA25, and tells us what it means to him to be president this year. youtu.be/dZvpDO-JpjM

AUA TV is back for one more scientific update from #AUA25! Today we're looking at a new major trial in Prostate, as well as the latest updates in post-treatment guidelines. youtu.be/TG1TQAgVVI0

Tune in as Dr. Roger Sur sits down with AUA TV in studio to discuss whether we need to do percutaneous nephrolithotomy anymore. #AUA25 youtu.be/hi7xJkyiUIQ

⚕️DAY 3 of AUA TV is NOW LIVE!⚕️

The AUA continues to set the highest standards for patient care & urologic education. Today, on our final day of #AUA25, we’re on a mission to get to the bottom of what drives the AUA in all the work they do. youtu.be/mwFkHlp0ZBw